CN108558976B - The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT - Google Patents
The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT Download PDFInfo
- Publication number
- CN108558976B CN108558976B CN201810333190.7A CN201810333190A CN108558976B CN 108558976 B CN108558976 B CN 108558976B CN 201810333190 A CN201810333190 A CN 201810333190A CN 108558976 B CN108558976 B CN 108558976B
- Authority
- CN
- China
- Prior art keywords
- ppd
- ppt
- ethyl acetate
- optional
- rare ginsenoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides the preparation methods for including the quasi- monomeric compound Δ PPD of rare ginsenoside (comprising Δ (20-21) PPD and isomer Δ (20-22) PPD) and the quasi- monomeric compound Δ PPT of rare ginsenoside (comprising Δ (20-21) PPT and isomer Δ (20-22) PPT), compared to the existing method for preparing rare ginsenoside, this preparation method is simple, cost is relatively low, simultaneously on this basis, the present invention also provides prepare rare ginsenoside monomeric compound Δ (20-21) PPD, Δ (20-22) PPD and rare ginsenoside monomeric compound Δ (20-21) PPT, the method of Δ (20-22) PPT;The method by simple column chromatography for separation technology, can low cost, high efficiency and on a large scale separation prepare the quasi- monomeric compound Δ PPD of rare ginsenoside and its monomer component and the quasi- monomeric compound Δ PPT of rare ginsenoside and its monomer component.
Description
Technical field
The present invention relates to field of medicaments, and in particular to the preparation method of a kind of low polarity rare ginsenoside.
Background technique
Cancer is to torture the second-biggest-in-the-world disease of human life, and the death rate is only second to cardiovascular and cerebrovascular disease, is that the mankind are dead
One of main factor died.Organize cancer mechanism, the official International Cancer Research Center (IARC) of subordinate negative by World Health Organization
The latest edition " report of world's cancer " of duty predicts that swift and violent proliferation situation will be presented in global cases of cancer, by 2012 14,000,000
People, fast 19,000,000 people for increasing to 2025, were up to 24,000,000 people by 2035 year by year.Report also shows that the whole world was new in 2012
Increasing cases of cancer has nearly half to appear in Asia, and wherein most ranks first in China, the newly-increased cases of cancer height of China.2012
Newly-increased 3,070,000 cancer patients of China simultaneously cause about 2,200,000 people dead, account for the 21.9% and 26.8% of global total amount respectively.WHO
Data be slightly below China statistics.2012 annual datas of national tumour Register publication show that China is annual newly-increased
Cases of cancer about 3,500,000, it is therefore dead that there are about 2,500,000 people.
There are mainly three types of modes for the common method for the treatment of of cancer now: operation, radiotherapy and drug therapy, and which is selected and is controlled
Treatment method then depends on position, grade malignancy, development degree and the patient body state of tumour.In Three models, operation
Treatment method, the invasion of Chang Yinwei cancer cell spreads to adjacent tissue or far-end transfer and effect is limited;The treatment method of radiotherapy, then
It is limited to the injury caused by other internal normal tissues;The treatment method of drug, it is pernicious for advanced stage dispersivity and metastatic
Tumour is most basic treatment method.In past decades, though the chemotherapy for being conceived to direct killing tumour cell has significantly
Development and progress becomes the backbone of tumor pharmacother, but this treatment mode is poor to the slow solid tumor effect of proliferation, drug
Selectivity is small, toxicity is more and serious defect becomes the important limiting factor in clinical treatment.After operation, radiation and chemotherapy
The 4th kind of mode later is the biological therapy of tumour, mainly passes through the effect of tumor host defense mechanism or biological agent
The biologically of body itself is adjusted, to suppress or eliminate tumour;Although biological therapy without too big toxic side effect,
Since technical requirements are tight, complex process, price is high, and numerous cancer patients and family members are difficult to bear, influence it and control in cancer
It popularizes in treatment field.
Since there are above-mentioned various limitations, the research and development of natural antitumor drug achieve more and more concerns.It is natural anti-
Cancer drug either in inhibition or killing tumor cell, adjustment body's immunity, improvement symptom and feature and mitigates chemicotherapy
In toxic side effect, or in the conditioning after being ill of tumour, all have important function.As a result, natural plants new treatment will become after
The 5th kind of mode after operation, radiotherapy, chemotherapy and biotherapy.
Araliaceae (araliaceae) Panax (Pana ×) plant, such as ginseng (P.ginseng), American Ginseng
(P.quenquefolinus), Radix Notoginseng (P.notoginseng), panax japonicus (P.uaponicus), cucurbitaceae genus gynostemma
Gynostemma pentaphylla (Gynostemma oentaphyllum Thrunb Mak) etc. is the rare traditional medicinal plant of China, main
Effective component is dammarane type four-ring triterpenoid ginseng saponin series compound.Have now been found that the prototype ginseng in Araliaceae
Saponin(e has more than 60 kinds, can be divided into two major classes: 1) glycol group ginsenoside (Ra, Rb1, Rb2, Rb3, Rc, Rd etc.);2) triol group people
Join saponin(e (Re, Rf, Rg1, Rg2, Rh1 etc.), is all made of glucoside member and sugar, is generally dissolved easily in water, curative effect specifically includes that immune
Regulatory function, improving micro_circulation effect adjust digestive function, enhancing memory and learning ability, anti-aging, tranquilizing the mind etc., but not
Show apparent anti-tumor activity.
Low polarity rare ginsenoside content in former panax species is little, exists only in wild ginseng or red ginseng, black
In ginseng and the ginseng and Radix Notoginseng product of processings such as ripe Radix Notoginseng, it is also only ten thousand/it is several, and it is insoluble in water, usually only it is dissolved in ethyl alcohol
Or in the low polar organic solvents such as ethyl acetate, referred to as low polarity rare ginsenoside mainly includes that prototype ginsenoside is logical
Cometabolism derivative (C-k, Rg3, Rh2, Rh1, aPPD, aPPT etc.) and the side chain desugar simultaneously crossing glycosidic bond degradation and generating
It is dehydrated conversion derivative (Rg5, Rk1, Rh3, Rk2, Δ (20-21) PPD, Δ (20-22) with more double bond structures formed
PPD, Rh4, Rk3, F4, Rg6, Δ (20-21) PPT, Δ (20-22) PPT etc.).Low polarity rare ginsenoside is in addition to general
Except the logical original bioactivity of prototype ginsenoside, also show that prototype saponin(e do not have is antitumor, antiviral etc. completely new
Pharmaceutical activity, have high medical value and application prospect.
Hasegawa show husband (Japan Kokai 8-291194) report the preparation method comprises the following steps: sour water solution is natural or 3 hydroxyls
Free ginsenoside, it is mono- that hydrolysate can get Δ (20-22) PPT and Δ (20-22) PPD after routine and chromatographic isolation
Product.The primary product of sour water solution ginsenoside is the panaxatriol and panoxadiol of side chain cyclisation, Δ (20-22) PPT and Δ
(20-22) PPD is only micro by-product, thus, Δ (20-22) PPT and the side PPD Δ (20-22) are prepared provided by the patent
Legal low to conversion ratio, product yield is low, isolates and purifies difficulty height, is not suitable with industrial production.·
Chinese patent CN1249076C, CN1249077C and CN1269835C report new compound: 1,3 β, 6 α,
12 β-three hydroxyls -20 (21), and 24 (25)-diene-dammarane [dammar-3 β, 6 α, 12 β-trihydro × yl-20 (21), 24
(25)-diene, abbreviation Δ (20-21) PPT.Δ (20-21) PPT is Δ (20-22) PPT configurational isomer, has Δ (20-
22) PPT similar bioactivity;And 2: 3 β, 12 β-dihydroxy -20 (21), 24 (25)-diene-Da Ma burn [dammar-3 β, 12
β-dihydroxyl-20 (21), 24 (25)-diene, abbreviation Δ (20-21) PPD].Δ (20-21) PPD is Δ (20-22) PPD
Configurational isomer, with the similar bioactivity of Δ (20-22) PPD, above-mentioned these types compound is needed using expensive
Protopanaxatriol group raw material or the production preparation of raw material monomer Ginsenoside F1, or need to utilize expensive protopanoxadiol
Group raw material or the production preparation of raw material monomer ginseng saponin C-K, are that industrial mass preparation cost is high, not can effectively solve Δ
The contradiction of the supply shortage of (20-22) PPT and Δ (20-22) PPD.Until up to now, still without one on domestic and international market
Enterprise, family can manufacture the rare metabolism ginsenoside and rare conversion ginseng soap of high-content (> 30-90%) on a large scale simultaneously
Glycosides, including the higher Δ of anticancer activity (20-21) PPT, Δ (20-22) PPT, Δ (20-21) PPD and Δ (20-22)
PPD.Therefore, the preparation method for studying above two low polarity rare ginsenoside, to the stronger ingredient of discovery activity and development
Anti-cancer agent will have great importance.
Summary of the invention
The technical problem to be solved in the present invention is to provide include the quasi- monomeric compound Δ PPD of rare ginsenoside and standard
The preparation method of monomeric compound Δ PPT, on this basis, the present invention also each provide the quasi- monomer of rare ginsenoside monomer
The method for preparing purified of compound Δ PPD and quasi- monomeric compound Δ PPT.
First aspect present invention provides the preparation method of above-mentioned rare ginsenoside comprising: dilute containing low polarity
Normal propyl alcohol, metallic sodium, benzoyl peroxide are sequentially added in the pyrolysis Araliaceae stem-leaf extract for having ginsenoside, and is led to
Oxygen, and reaction solution heating reaction is made, wherein the pyrolysis Araliaceae containing low polarity rare ginsenoside is excellent
Selected from wild ginseng, red ginseng, black ginseng, American Ginseng and Radix Notoginseng;
In a preferred example, the heating reaction carries out in four-hole bottle, and the four-hole bottle is passed through equipped with thermometer, oxygen
Seal rubber pipe, condenser pipe are connected on pipe, top, the rubber tube other end connects funnel, and the funnel, which immerses, is equipped with liquid stone
The beaker of wax,
In a preferred example, normal propyl alcohol is added to stir 10 minutes later,
In a preferred example, metallic sodium is added, reaction to no hydrogen is released,
In a preferred example, the heating reaction is reacted 24 hours for 86 DEG C,
In a preferred example, reaction solution after reaction, is cooled to room temperature, then washed reaction liquid by the heating, will
It is dissolved after the normal propyl alcohol layer decompressing and extracting of reaction solution with water, then uses the low polar substances of n-hexane extraction, subsequently use acetic acid second
Ester extraction, is evaporated ethyl acetate portion and obtains rare ginsenoside.
In a preferred example, ethyl acetate solution ultrasound is added in the rare ginsenoside obtained, added just
Hexane filters after shaking up standing, after the ethyl acetate ultrasound that filter residue adds is obtained by filtration, after the n-hexane of addition shakes up standing
Filtering, merging filtrate are simultaneously concentrated;
In a preferred example, the addition ethyl acetate solution ultrasound 30min.
The second aspect of the present invention additionally provides the quasi- monomeric compound Δ PPD of rare ginsenoside and quasi- monomeric compound Δ
The purification process of PPT comprising: take silica gel the first ethyl acetate of addition and n-hexane solvent to stir evenly dress column, first acetic acid
The volume ratio of ethyl acetate n-hexane is 1:2, the concentrate and silicon that the merging filtrate is obtained in ethyl ester and n-hexane solvent
Glue mixes sample, and will mix the silica gel after sample it is finely ground after fill column, first rinse 3 with first ethyl acetate and hexane solution and retain
Volume, the 2nd and the 3rd retention volume collects quasi- monomeric compound Δ PPD, then rushes 3 with the second ethyl acetate and hexane solution 1:1
A retention volume rinses altogether 6 retention volumes, ethyl acetate n-hexane in second ethyl acetate and n-hexane solvent
Volume ratio is that the retention volume of 1:1, the 5th and the 6th collects quasi- monomeric compound Δ PPT;
In a preferred example, silica gel is 200-300 mesh,
In a preferred example, the long 20cm wide 4cm of silicagel column specification after column is filled,
In a preferred example, the chromatographic column retention volume after the dress column is 200ml.
In a preference of first aspect present invention and second aspect, the heat containing low polarity rare ginsenoside
Solution Araliaceae stem-leaf extract is made with the following method: after gen-seng haulms are broken into powder, Ginseng stem leaf powder being placed on steaming
Then boiling Ginseng stem leaf powder is dried in vacuo to obtain dry boiling Ginseng stem leaf powder, with 95% second by boiling in vapour pressure cooker
Alcohol impregnates dry boiling Ginseng stem leaf powder, then filters, filtrate is concentrated to get gen-seng haulms powder extracts;
It is in a preferred example, described that gen-seng haulms are broken into powder using pulverizer,
In a preferred example, the boiling in steam autoclave be 120 DEG C, boiling 20h under 0.15MPa pressure,
In a preferred example, by the vacuum drying of boiling Ginseng stem leaf powder to be placed in oven and dried 8h at 80 DEG C,
In a preferred example, described the step of filtrate is concentrated to get Ginseng stem leaf powder ethanol extract further include: by second
Alcohol recycling is reused, and is impregnated filter residue 5 times, and merging finally obtains boiling extract of Radix Ginseng stem and leaf.
Terminology used in the present invention have it is defined below, unless otherwise described:
The term as used herein " rare ginsenoside " means to mainly contain one or more rare ginsenoside singulations
Close object Δ (20-21) PPD, Δ (20-22) PPD and Δ (20-21) PPT, Δ (20-22) PPT or the quasi- monomer of rare ginsenoside
Compound Δ PPD and Δ PPT.
The term as used herein " the quasi- monomeric compound Δ PPD of rare ginsenoside " means to have the following structure the rare of formula
Ginsenoside monomer Δ (20-21) PPD:
And have the following structure the compound of isomer rare ginsenoside Δ (20-22) PPD of formula a kind of:
The term as used herein " the quasi- monomeric compound Δ PPT of rare ginsenoside " means to have the following structure the rare of formula
Ginsenoside monomer Δ (20-21) PPT:
And have the following structure the compound of isomer rare ginsenoside Δ (20-22) PPT of formula a kind of:
The present invention provides include the quasi- monomeric compound Δ PPD of rare ginsenoside and the quasi- singulation of rare ginsenoside
The preparation method for closing the composition of object Δ PPT, compared to the existing method for preparing rare ginsenoside, this preparation method is simple,
Cost is relatively low, while on this basis, and the present invention also provides prepare rare ginsenoside monomer Δ PPD and rare ginsenoside
The method of monomer Δ PPT, the method low cost, high efficiency and can be divided on a large scale by simple column chromatography for separation technology
From the quasi- monomeric compound Δ PPD of rare ginsenoside and the quasi- monomeric compound Δ PPT of rare ginsenoside is prepared, further to open
Hair related drugs lay the foundation.
Detailed description of the invention
Fig. 1 is the schematic arrangement of rare ginsenoside monomer Δ (20-21) PPD.
Fig. 2 is the schematic arrangement of rare ginsenoside monomer Δ (20-22) PPD.
Fig. 3 is the schematic arrangement of rare ginsenoside monomer Δ (20-21) PPT.
Fig. 4 is the schematic arrangement of rare ginsenoside monomer Δ (20-22) PPT.
Specific embodiment
The cracking reaction of glycosidic bond occurs during steaming for the main component ginsenoside in Araliaceae extract
Although the rare saponin component new with can produce Rh1, Rk3, Rh4, Rg3, Rg5, Rk1 etc. after the dehydration of side chain,
The stronger rare saponins of activity: Rh2, Rk2, Rh3, aPPT, aPPD, Δ are formed to the glycosidic bond of further break off remnant
The ingredients such as PPT, Δ PPD are relatively difficult.It, can be further although being reacted under conditions of strong acid or weak acid (high temperature) after steaming
The glycosidic bond of break off remnant, but many side reactions can also occur simultaneously, such as: the ring-closure reaction of side chain, pendant double bonds
Addition reaction etc., can only isolated a small amount of rare saponin(e Rh2, Rk2, Rh3, aPPT, aPPD, Δ PPT, Δ PPD ingredient,
Preparation can not be mass produced and realize really application.It, can if carrying out dual oxide reaction after steaming under alkaline condition
To avoid the above side chain side reaction, the large scale preparation of rare saponin component is realized.Meanwhile it is not pre- in the present invention
It first carries out complex process and expensive protoplast joins two/triol group raw material or prepared by the separation of monomeric compound raw material,
But dual oxide alkaline hydrolysis again after directlying adopt prototype Araliaceae heating cracking, extracting, it is finally separating purifying, saves technique
Cost is conducive to industrialized production.
First aspect present invention provides the synthesis preparation method of above-mentioned rare ginsenoside composition comprising: containing
Normal propyl alcohol, metallic sodium, peroxidating are sequentially added in the pyrolysis Araliaceae stem-leaf extract for having low polarity rare ginsenoside
Benzoyl, and logical oxygen, and reaction solution heating reaction is made, wherein the pyrolysis containing low polarity rare ginsenoside
Araliaceae preferably is selected from wild ginseng, red ginseng, black ginseng, American Ginseng and Radix Notoginseng;
In a preferred example, the heating reaction carries out in four-hole bottle, and the four-hole bottle is passed through equipped with thermometer, oxygen
Seal rubber pipe, condenser pipe are connected on pipe, top, the rubber tube other end connects funnel, and the funnel, which immerses, is equipped with liquid stone
The beaker of wax,
In a preferred example, normal propyl alcohol is added to stir 10 minutes later,
In a preferred example, metallic sodium is added, reaction to no hydrogen is released,
In a preferred example, the heating reaction is reacted 24 hours for 86 DEG C,
In a preferred example, reaction solution after reaction, is cooled to room temperature, then washed reaction liquid by the heating, will
It is dissolved after the normal propyl alcohol layer decompressing and extracting of reaction solution with water, then uses the low polar substances of n-hexane extraction, subsequently use acetic acid second
Ester extraction, is evaporated ethyl acetate portion and obtains rare ginsenoside.
In a preferred example, ethyl acetate solution ultrasound is added in the rare ginsenoside obtained, added just
Hexane filters after shaking up standing, after the ethyl acetate ultrasound that filter residue adds is obtained by filtration, after the n-hexane of addition shakes up standing
Filtering, merging filtrate are simultaneously concentrated;
In a preferred example, the addition ethyl acetate solution ultrasound 30min.
The second aspect of the present invention additionally provides the purifying side of rare ginsenoside quasi- monomeric compound Δ PPD and Δ PPT
Method comprising: take silica gel the first ethyl acetate of addition and n-hexane solvent to stir evenly dress column, first ethyl acetate and n-hexane
The volume ratio of ethyl acetate n-hexane is 1:2, the concentrate and silica gel mixed sample that the merging filtrate is obtained, and mixing in solvent
Column is filled after silica gel after sample is finely ground, first with first ethyl acetate and hexane solution 3 retention volumes of flushing, the 2nd and the 3rd
Retention volume collects Δ PPD, then rushes 3 retention volumes with the second ethyl acetate and hexane solution 1:1, rinses 6 guarantors altogether
Volume is stayed, the volume ratio of ethyl acetate n-hexane is the reservation of 1:1, the 5th and the 6th in second ethyl acetate and n-hexane solvent
Volume collection Δ PPT;
In a preferred example, silica gel is 200-300 mesh,
In a preferred example, the long 20cm wide 4cm of silicagel column specification after column is filled,
In a preferred example, the chromatographic column retention volume after the dress column is 200ml.
In a preference of first aspect present invention and second aspect, the extract of Radix Ginseng stem and leaf is made with the following method
: after gen-seng haulms are broken into powder, Ginseng stem leaf powder is placed on boiling in steam autoclave, then by boiling Ginseng stem leaf powder
Vacuum drying obtains dry boiling Ginseng stem leaf powder, and dry boiling Ginseng stem leaf powder is impregnated with 95% ethyl alcohol, is then filtered,
Filtrate is concentrated to get gen-seng haulms powder extracts;
It is in a preferred example, described that gen-seng haulms are broken into powder using pulverizer,
In a preferred example, the boiling in steam autoclave be 120 DEG C, boiling 20h under 0.15MPa pressure,
In a preferred example, by the vacuum drying of boiling Ginseng stem leaf powder to be placed in oven and dried 8h at 80 DEG C,
In a preferred example, described the step of filtrate is concentrated to get Ginseng stem leaf powder ethanol extract further include: by second
Alcohol recycling is reused, and is impregnated filter residue 5 times, and merging finally obtains boiling extract of Radix Ginseng stem and leaf.
Unless specifically indicated, term used herein has the general sense in fields of the present invention.
Below with reference to specific embodiment, the present invention will be described, it should be noted that these embodiments are only explanation
Property, and be not considered as limiting the invention.Particular technique or condition are not specified in embodiment, according in the art
Technology or conditions described in document are carried out according to product description.Reagents or instruments used without specified manufacturer,
Being can be with conventional products that are commercially available.
Embodiment 1 prepares low polarity rare ginsenoside composition and low polarity rare ginsenoside monomer Δ from ginseng
The method of (20-21) PPT, Δ (20-22) PPT, Δ (20-21) PPD and Δ (20-22) PPD
Present embodiments provide a kind of low polarity rare ginsenoside monomer Δ (20-21) PPT for the formula of having the following structure
Preparation method:
And have the following structure the preparation method of low polarity rare ginsenoside monomer Δ (20-22) PPT of formula a kind of:
Meanwhile the present embodiment additionally provides low polarity rare ginsenoside composition and has the following structure a kind of low of formula
The preparation method of polarity rare ginsenoside monomer Δ (20-21) PPD:
And have the following structure the preparation method of low polarity rare ginsenoside monomer Δ (20-22) PPD of formula a kind of:
(1) it extracts and prepares:
The gen-seng haulms (1.0kg) for originating from Jilin bought from Chinese medicine wholesale market, are placed after breaking into powder with pulverizer
In medical steam autoclave, the boiling 20h under 120 DEG C, 0.15MPa pressure, (Ginseng stem leaf powder will avoid mixed with water as far as possible
It closes);It is then placed in baking oven the vacuum drying 8h at 80 DEG C and obtains dry boiling Ginseng stem leaf powder, soaked with 95% ethyl alcohol of 5kg
Bubble two days, filtering, filtrate are concentrated to get boiling Ginseng stem leaf powder ethanol extract.Ethyl alcohol recycling, which is reused, impregnates filter residue 5 times,
Merging finally obtains boiling extract of Radix Ginseng stem and leaf 650g.
Seal rubber pipe is connected on equipped with thermometer, oxygen access tube, top, and (the rubber tube other end connects a funnel, leaching
Enter in the beaker equipped with atoleine), in the four-hole bottle of the 2L of condenser pipe, be added 200 grams of boiling extract of Radix Ginseng stem and leaf and
1500ml normal propyl alcohol, stirring after ten minutes, are added 60 grams of metallic sodiums, when reaction to no hydrogen is released, benzoyl peroxide are added
10 grams, start logical oxygen, and reaction solution is heated to 86 DEG C and is reacted 24 hours.After reaction, reaction solution is cooled to room temperature, water
It washes three times, is dissolved after normal propyl alcohol layer decompressing and extracting with water, first use the low polar substances of n-hexane extraction, then extracted with ethyl acetate
It takes, is evaporated ethyl acetate portion and obtains rare ginsenoside crude mixture 70g, crude product is refined using following silicon column chromatographic technique
Rare ginsenoside monomer.
(2) separating technology process:
In diagram, low polarity rare ginsenoside monomer Δ PPT1Refer to Δ (20-21) PPT, Δ PPT2Refer to Δ (20-22)
PPT, Δ PPD1Refer to Δ (20-21) PPD, Δ PPD2Refer to Δ (20-22) PPD.
(3) operating process and process conditions
The extraction of rare ginsenoside crude product
Purpose: active principle is extracted using dissolution sex differernce removal pigment.
Method: it takes rare ginsenoside crude product 20g that the ethyl acetate solution ultrasound 30min of 200ml is added, adds
The n-hexane of 200ml filters after shaking up standing, and 100ml is being added just after adding the ethyl acetate ultrasound 30min of 100ml in filter residue
Hexane filters after shaking up standing, and merging filtrate is simultaneously concentrated.
Silica gel post separation Δ PPD, Δ PPT
Purpose: using silica gel post separation Δ PPD, Δ PPT and most of pigment is removed
Method: it takes 90g silica gel (200-300 mesh) that 300ml (ethyl acetate: n-hexane 1:2) solution is added and stirs evenly dress column, silicon
The long 20cm wide 4cm of rubber column gel column specification.Concentrate and 15g silica gel mixed sample, and will mix the silica gel after sample it is finely ground after fill column.Retention volume is big
It is generally 200ml, first use ethyl acetate: n-hexane 1:2 rushes 3 retention volumes, then with ethyl acetate: n-hexane 1:1 rushes 3 reservations
Volume totally 6 retention volumes.2nd, 3 retention volumes collect Δ PPD, the 5th, 6 retention volumes collection Δ PPT.
Quickly preparation is pressed in Δ PPD
Purpose: preparation purification Δ (20-22) PPD simultaneously removes most of pigment
Chromatographic column: quickly preparation Detection wavelength: 203 flow velocity 20ml/min is pressed in C18 40g 40-60um instrument Agela
Method: 95% acetonitrile water is isocratic, appearance time 15-25min, sample volume 300mg.Remainder is Δ (20-21)
PPD
Δ PPD, the preparation of Δ PPT high-voltage high-speed
Purpose: purification Δ PPD and Δ PPT simultaneously removes depigmentaton
Chromatographic column: Waters Symmetry C18 7um 19*250 instrument Aglient Detection wavelength: 203nm flow velocity:
10ml/min
Δ PPT preparation method: 70% acetonitrile is isocratic, appearance time 20-25min, sample volume 100mg.
Δ PPD preparation method: 90% acetonitrile is isocratic, and appearance time 15-20min, sample volume 100mg goes the purity of depigmentation
Higher Δ PPD, Δ PPT method for crystallising
Purpose: it is purified using method for crystallising
Δ PPD method for crystallising: 70% or more Δ PPD2 preparation solution is concentrated into the muddy addition total 100- of methanol by several times of liquid
200ml is threaded to volume 20ml and is put in 4 degree of refrigerators standings.
Δ PPT method for crystallising: a small amount of methanol 15ml is added to being completely dissolved in 70% or more Δ PPT2 preparation solution after being spin-dried for
Naturally volatilization crystallization.
Embodiment 2 prepares low polarity rare ginsenoside composition and low polarity rare ginsenoside monomer Δ from Radix Notoginseng
The preparation method of (20-21) PPT, Δ (20-2122) PPT, Δ (20-21) PPD and Δ (20-22) PPD
It extracts and prepares:
The notoginseng haulm (1.0kg) bought from Chinese medicine wholesale market, is placed on medical steam after breaking into powder with pulverizer
In pressure cooker, the boiling 20h under 120 DEG C, 0.15MPa pressure, (notoginseng haulm powder will avoid mixing with water as far as possible);It is then placed in
8h is dried in vacuo in baking oven at 80 DEG C and obtains dry boiling Ginseng stem leaf powder, is impregnated two days with 95% ethyl alcohol of 5kg, filtering,
Filtrate is concentrated to get boiling notoginseng haulm powder ethanol extract.Ethyl alcohol recycling, which is reused, impregnates filter residue 5 times, and merging finally obtains
Boiling Panax Notoginseng Folium Saponins 550g.
Separating-purifying and method for crystallising are the same as embodiment 1.
Comparative example 1: in heated or slightly sour environment, hypoglycemic hydrolysis occurs for the general ginsenoside part in ginseng or Radix Notoginseng can
Generate the secondary saponin(e of ginseng
(1) it raw material pre-treatment: is crushed after the impurity such as silt are removed in the washing of American Ginseng sun-dried ginseng, crosses 40 meshes;
(2) steam explosion is handled: ginseng powder is soaked with 10% acetic acid, is made its water content 35%, is placed in steam-explosion jar, is passed through steam
To steam explosion pressure inside the tank be 1.5MPa, Steam explosion treatment 60 minutes;
(3) biological complex enzyme is handled: raw material after steam explosion being adjusted water content with water as 40%, is 0.5% by material ratio
It (includes cellulase 25%, alpha-amylase 25%, zytase 10%, laccase 5%, albumen that biological complex enzyme preparation, which is added, in amount
Enzyme 20%, pectase 10%, mannase 5%), it is uniformly mixed, hydrolyzes 5h under the conditions of pH5.5,30 DEG C;
(4) dry sterilization: obtained reaction system will be handled through (3), be dried under reduced pressure, microwave sterilization;
(5) detect: sampling ginseng powder raw material carries out batch examining, ginsenoside in test sample (including monomer ginsenoside
Rg3, Rh2), panaxan, ginseng protein content;
(6) it packs: being examined qualified ginseng powder by every barrel of 25kg packaging, sealed up for safekeeping.
But these needs react at higher temperature and stronger acid condition, and product is easy to happen side chain cyclisation at this time
And the secondary saponin(e of ginseng for forming panoxadiol and panaxatriol type, while also occurring that other side reactions, it is difficult on a large scale
Prepare the secondary saponin(e of the stronger ginseng of pharmacological activity (Rk1/Rg5, Rk3/Rh4 and Rk2/Rh3).
On the other hand, preparing the secondary saponin(e of ginseng (Rg3, Rh1, Rh2) can also be carried out by Base hydrolysis method, in alkalinity
Under the conditions of hydrolyze, Rh1, aPPT can be obtained in triol group ginsenoside;Rg3, Rh2, aPPD can be obtained in glycol group ginsenoside.
Comparative example 2
10gNaOH is dissolved in the ethylene glycol solution of 100ml, 10g panax quinquefolium saponin is added, stirs lower heating
It being hydrolyzed 1 hour, temperature is controlled at 190 DEG C, 50 times of water dilution is added after being cooled to room temperature, then be extracted with ethyl acetate,
Recycle ethyl acetate, obtain product 7g, through TLC prove wherein containing Ginsenoside Rg3, Rh2, Rh1, Rg2 and protopanoxadiol and
Protopanaxatriol.
Comparative example 3
Radix Notoginseng 18kg (specification: countless heads are purchased from Yunnan) is pulverized into powder (100-200 mesh), with 95% ethyl alcohol of 30kg
It impregnates two days, filtering, filtrate is concentrated to give Radix Notoginseng ethanol extract, and ethyl alcohol recycling, which is reused, impregnates filter residue six times, final accumulative
Radix Notoginseng ethanol extract 3.37kg is obtained, is dissolved in water, is extracted three times with petroleum ether, water intaking is mutually extracted four times with n-butanol,
N-butanol layer concentration, there are arasaponin n-butanol extract 1.78kg.
It takes total saponin extracts 100g to be dissolved in 1300ml n-butanol, heats, stirring, sodium ethoxide is added, and (chemistry is pure, pure
Degree: 80%) 132.6g (1.56mol, concentration: 1.2mol/L) leads to oxygen, and 90 DEG C are reacted 65 hours, and reaction terminates.Reaction solution is cooled to
Room temperature, the washing being saturated with n-butanol are dissolved after n-butanol layer concentration with water, and ethyl acetate extracts, and ethyl acetate washed with water is washed,
It is dry.After concentration, is purified through silica gel column chromatography [1~5% methanol/chloroform solution gradient elution], obtains protopanoxadiol (A2) 6g,
It is 97.93% that HPLC, which measures purity,;It is 99.95% that protopanaxatriol (A3) 11g, HPLC, which measure purity,.Compound (A3) measurement
Physicochemical data be coincident with literature value: Chen Yingjie et al, Journal of Shenyang College of
Pharmacy, 1987,4 (4), 282-289.
The physicochemical data of compound (A3) measurement is as follows:
1H NMR (300MHz, CDCl3): δ 5.18 (d, 1H), 4.14 (m, 1H), 3.6 (m, 1H), 3.2 (s, 1H), 2.15-
1.61 (m, 20H), 1.58-1.17 (m, 12H), 1.05 (s, 5H), 1.01 (s, 3H), 0.95 (d, 8H).
13C NMR (300MHz, CDCl3): 132.1,125.2,78.8,74.7,71.0,68.9,61.4,53.7,51.7,
49.8,47.7,47.2,41.2,39.6,39.4,39.1,34.8,31.4,31.3,31.2,27.3,27.2,26.7,26.0,
22.6,18.0,17.5,17.4,17.1,15.8.
It is above-mentioned to be shared using Base hydrolysis method the disadvantage is that target product low yield, reaction temperature is high, especially basic hydrolysis people
C-20 spatial configurations do not change when joining saponin(e, and-the H on-OH and the position C-21 or C-22 on the position C-20 will not be dehydrated
And double bond is formed between C-20 and C-21 or C-22, therefore, it is impossible to directly prepare the secondary saponin(e of novel ginseng by basic hydrolysis
(Rk1/Rg5, Rk3/Rh4, Rk2/Rh3 etc.).
Claims (3)
1. a kind of preparation method of rare ginsenoside comprising: the pyrolysis slender acanthopanax containing low polarity rare ginsenoside
Section's plant stem-leaf extract is made with the following method: after the pyrolysis Araliaceae cauline leaf is broken into powder, by the cauline leaf powder
It is placed on boiling in steam autoclave, cauline leaf powder described in boiling then is dried in vacuo to obtain cauline leaf powder described in dry boiling,
Cauline leaf powder described in dry boiling is impregnated with 95% ethyl alcohol, then filters, filtrate is concentrated to get the cauline leaf powder extracts;?
Normal propyl alcohol, metallic sodium, peroxide are sequentially added in pyrolysis Araliaceae stem-leaf extract containing low polarity rare ginsenoside
Change benzoyl, and logical oxygen, and reaction solution heating reaction is made, wherein the heat containing low polarity rare ginsenoside
It solves Araliaceae and is selected from ginseng, American Ginseng and Radix Notoginseng;The rare ginsenoside is to contain one or more rare ginseng soaps
Glycosides monomeric compound Δ (20-21) PPD, Δ (20-22) PPD and Δ (20-21) PPT, Δ (20-22) PPT or rare ginseng soap
Glycosides quasi- monomeric compound Δ PPD and Δ PPT;
It is optional, it is described that the cauline leaf is broken into powder using pulverizer,
Optional, the boiling in steam autoclave is 120 DEG C, boiling 20h under 0.15MPa pressure,
Optional, by the vacuum drying of cauline leaf powder described in boiling to be placed in oven and dried 8h at 80 DEG C,
Optional, described the step of filtrate is concentrated to get the cauline leaf powder ethanol extract further include: ethyl alcohol is recycled and is repeated
It using, impregnates filter residue 5 times, merging finally obtains stem-leaf extract described in boiling,
Optional, the heating reaction carries out in four-hole bottle, and the four-hole bottle on thermometer, oxygen access tube, top equipped with connecting
There are seal rubber pipe, condenser pipe, the rubber tube other end connects funnel, and the funnel immerses the beaker that atoleine is housed,
Optional, it is added after normal propyl alcohol stirring 10 minutes,
Optional, metallic sodium is added, reaction to no hydrogen is released,
Optional, the heating reaction is reacted 24 hours for 86 DEG C,
Optional, reaction solution after reaction, is cooled to room temperature, then washed reaction liquid, just by reaction solution by the heating
It is dissolved after propyl alcohol layer decompressing and extracting with water, then uses the low polar substances of n-hexane extraction, be subsequently extracted with ethyl acetate, be evaporated
Ethyl acetate portion obtains rare ginsenoside.
2. preparation method according to claim 1, which is characterized in that ethyl acetate is added in the rare ginsenoside obtained
Solution ultrasound, the n-hexane added filter after shaking up standing, after the ethyl acetate ultrasound that filter residue adds is obtained by filtration, are added
N-hexane shake up standing after filter, merging filtrate is simultaneously concentrated;
Optional, the addition ethyl acetate solution ultrasound 30min.
3. preparation method according to claim 2, which is characterized in that silica gel the first ethyl acetate of addition and n-hexane solvent is taken to stir
Even dress column, the volume ratio of ethyl acetate n-hexane is 1:2 in first ethyl acetate and n-hexane solvent, and merging filtrate is obtained
The concentrate and silica gel mixed sample arrived, and will mix the silica gel after sample it is finely ground after fill column, first with first ethyl acetate and n-hexane
Solution rinses 3 retention volumes, and the 2nd and the 3rd retention volume collects Δ (20-21) PPD and Δ (20-22) PPD, then with the second second
Acetoacetic ester and hexane solution 1:1 rush 3 retention volumes, rinse 6 retention volumes altogether, second ethyl acetate and just oneself
The volume ratio of ethyl acetate n-hexane is that the retention volume of 1:1, the 5th and the 6th collects Δ (20-21) PPT and Δ (20- in alkane solvents
22)PPT;
Optional, silica gel is 200-300 mesh,
Optional, the long 20cm wide 4cm of silicagel column specification after filling column,
Optional, the chromatographic column retention volume after the dress column is 200ml.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810333190.7A CN108558976B (en) | 2018-04-13 | 2018-04-13 | The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810333190.7A CN108558976B (en) | 2018-04-13 | 2018-04-13 | The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108558976A CN108558976A (en) | 2018-09-21 |
CN108558976B true CN108558976B (en) | 2019-09-06 |
Family
ID=63535014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810333190.7A Active CN108558976B (en) | 2018-04-13 | 2018-04-13 | The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108558976B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1269835C (en) * | 2002-12-13 | 2006-08-16 | 中国科学院大连化学物理研究所 | Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
CN1249076C (en) * | 2002-12-13 | 2006-04-05 | 中国科学院大连化学物理研究所 | Anti-tumour ginseng saponin aglycone derivatives |
CN1252082C (en) * | 2004-04-29 | 2006-04-19 | 上海中药创新研究中心 | Process for preparing protopanoxadiol and protopanaxatriol |
CN100584855C (en) * | 2005-11-01 | 2010-01-27 | 中山以诺生物科技有限公司 | Method for preparing protopanoxadiol and protopanaxatriol by using synergistic oxidation and alkaline bydrolysis of oxide and hyperoxide |
-
2018
- 2018-04-13 CN CN201810333190.7A patent/CN108558976B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN108558976A (en) | 2018-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101367881B (en) | High-efficiency preparation method for glossy ganoderma polysaccharide | |
RU2395518C2 (en) | Method of producing timosaponin bii | |
CN104894204A (en) | Method for preparing ginseng rare saponin by virtue of microorganism enzymatic conversion of ginsenosid Re | |
CN105648021A (en) | Preparation method for rare ginsenoside C-K and F1 and four kinds of isomer ginsengenin | |
CN105832748A (en) | Method for preparing novel mogrol derivatives from momordica grosvenori total saponins | |
CN112300242B (en) | Preparation method of furostanol saponin compound monomer | |
CN108822178A (en) | The preparation method of low polarity rare ginsenoside Rg5/Rk1 and Rh3/Rk2 | |
CN106632577B (en) | A kind of Ursane triterpenoid saponin and its preparation process in masson pine branch | |
CN104327148A (en) | Compounds with antitumor activity, and preparation method and application thereof | |
CN105601694B (en) | A method of extraction ginsenoside Rg 5 | |
Verotta et al. | Cycloartane and oleanane saponins from Astragalus sp. | |
CN101768202A (en) | Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof | |
CN100453550C (en) | Gen-seng saponin Rb2 preparation process | |
CN104311623A (en) | Pentacyclic triterpenoid compounds called Oleifearsaponin C1 and Oleifearsaponin C2 and preparation methods and application of pentacyclic triterpenoid compounds | |
CN101665527A (en) | Ginsenoside, preparation method thereof and use thereof | |
CN108558976B (en) | The preparation method of low polarity rare ginsenoside Δ PPD and Δ PPT | |
CN105832789A (en) | Method for preparing saponin enriched product through high-pressure microwave assisted semi-bionic extraction | |
CN100584855C (en) | Method for preparing protopanoxadiol and protopanaxatriol by using synergistic oxidation and alkaline bydrolysis of oxide and hyperoxide | |
CN1091448C (en) | Method for preparing 20(S)-ginsenoside-RH2, medicinal compositions therewith and use thereof | |
CN107326059A (en) | A kind of preparation method and applications of the high activity aging ingredient of natural origin | |
CN109400665B (en) | Method for preparing four triterpenoid compound reference substances from pubescent holly root | |
CN105037313B (en) | A kind of method of myricetrin and catechin compounds in separation Chinese waxmyrtle bark | |
CN106554384B (en) | A method of purifying otoginsenoside from buckeye medicinal extract | |
CN106543117B (en) | With anti-tumor activity double tetrahydrofuran type Annonaceousacetogenicompounds compounds and the preparation method and application thereof | |
CN103755774B (en) | The isolation identification of liriope muscari Baily inclined promise type steroid saponin compound and purposes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |